Found: 17
Select item for more details and to access through your institution.
Recommendations for Cost-Conscious Treatment of Basal Cell Carcinoma.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 9, p. 1959, doi. 10.1007/s13555-023-00989-x
- By:
- Publication type:
- Article
The Prevalent Comorbidome at the Onset of Psoriasis Diagnosis.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 9, p. 2093, doi. 10.1007/s13555-023-00986-0
- By:
- Publication type:
- Article
The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 9, p. 2121, doi. 10.1007/s13555-023-00985-1
- By:
- Publication type:
- Article
Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 9, p. 2031, doi. 10.1007/s13555-023-00979-z
- By:
- Publication type:
- Article
Real-World Treatment Patterns in Patients with Vitiligo in the United States.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 9, p. 2079, doi. 10.1007/s13555-023-00983-3
- By:
- Publication type:
- Article
Reinforcing Photoprotection for Skin of Color: A Narrative Review.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 9, p. 1935, doi. 10.1007/s13555-023-00982-4
- By:
- Publication type:
- Article
Racial and Ethnic Differences in Sociodemographic, Clinical, and Treatment Characteristics Among Patients with Atopic Dermatitis in the United States and Canada: Real-World Data from the CorEvitas Atopic Dermatitis Registry.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 9, p. 2045, doi. 10.1007/s13555-023-00980-6
- By:
- Publication type:
- Article
Basal Cell Carcinoma After High Dose Rate Brachytherapy: Medium-term Dermoscopic Evaluation of Cancer's Response.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 9, p. 2063, doi. 10.1007/s13555-023-00981-5
- By:
- Publication type:
- Article
Correction: Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 9, p. 1909, doi. 10.1007/s13555-023-00978-0
- By:
- Publication type:
- Article
Correction to: The Needs of Patients with Psoriasis and Benefits of Apremilast in French Clinical Practice: Results from the Observational REALIZE Study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Early Discontinuation of Apremilast in Patients with Psoriasis and Gastrointestinal Comorbidities: Rates and Associated Risk Factors.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 9, p. 2019, doi. 10.1007/s13555-023-00975-3
- By:
- Publication type:
- Article
Patient Experience of Lichen Planus: A Qualitative Exploration of Signs, Symptoms, and Health-Related Quality of Life Impacts.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 9, p. 2001, doi. 10.1007/s13555-023-00968-2
- By:
- Publication type:
- Article
Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 9, p. 2107, doi. 10.1007/s13555-023-00965-5
- By:
- Publication type:
- Article
Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 9, p. 1973, doi. 10.1007/s13555-023-00967-3
- By:
- Publication type:
- Article
Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 9, p. 1987, doi. 10.1007/s13555-023-00960-w
- By:
- Publication type:
- Article
Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 9, p. 1893, doi. 10.1007/s13555-023-00948-6
- By:
- Publication type:
- Article